{"date":"2025-07-28","count":32,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6734-2025-07-28-1920-1ce86i1","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2025-07-28","time":"19:20:01","subject":"公告本公司第四屆薪資報酬委員會新任委員名單","clause":"第6款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2025-07-28 19:20，「公告本公司第四屆薪資報酬委員會新任委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2025-07-28-1909-b6ss4a","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2025-07-28","time":"19:09:43","subject":"美國食品藥物管理局同意本公司以研發中新藥ABT-301與免疫檢查點抑制劑(tislelizumab)及抗血管新生抑制劑(bevacizumab)三藥合併應用於晚期大腸直腸癌(mCRC)的Phase 1/2臨床試驗。","clause":"第9款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2025-07-28 19:09，「美國食品藥物管理局同意本公司以研發中新藥ABT-301與免疫檢查點抑制劑(tislelizumab)及抗血管新生抑制劑(」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-07-28-1818-1ri5un1","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-07-28","time":"18:18:47","subject":"代重要子公司鼎晉生技股份有限公司公告董事會決議解除經理人競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-07-28 18:18，「代重要子公司鼎晉生技股份有限公司公告董事會決議解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6844-2025-07-28-1801-1tkkj4d","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2025-07-28","time":"18:01:21","subject":"公告本公司114年第二季財務報告董事會召開日期","clause":"第31款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2025-07-28 18:01，「公告本公司114年第二季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6875-2025-07-28-1757-1surenn","company_id":"6875","company":"國邑*","market":"上櫃","industry":"生技醫療","date":"2025-07-28","time":"17:57:54","subject":"公告本公司114年第2季財務報告董事會召開日期","clause":"第31款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：國邑*（6875），2025-07-28 17:57，「公告本公司114年第2季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2025-07-28-1747-tubi77","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2025-07-28","time":"17:47:17","subject":"代重要子公司曜胜生技股份有限公司公告法人董事改派代表人","clause":"第6款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2025-07-28 17:47，「代重要子公司曜胜生技股份有限公司公告法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1813-2025-07-28-1741-1kqsn3a","company_id":"1813","company":"寶利徠","market":"上櫃","industry":"生技醫療","date":"2025-07-28","time":"17:41:58","subject":"公告本公司114年第2季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：寶利徠（1813），2025-07-28 17:41，「公告本公司114年第2季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2025-07-28-1736-4aov2q","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2025-07-28","time":"17:36:41","subject":"公告本公司實際處分益安生醫(股)公司股票達公告標準","clause":"第20款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2025-07-28 17:36，「公告本公司實際處分益安生醫(股)公司股票達公告標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2025-07-28-1715-1roellr","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2025-07-28","time":"17:15:20","subject":"公告本公司董事辭任","clause":"第6款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2025-07-28 17:15，「公告本公司董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2025-07-28-1713-1tkkj4d","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2025-07-28","time":"17:13:23","subject":"公告本公司114年第二季財務報告董事會召開日期","clause":"第31款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2025-07-28 17:13，「公告本公司114年第二季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-07-28-1712-1ma8ceb","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-07-28","time":"17:12:46","subject":"公告本公司今日接獲註冊代理人通知，摩洛哥AMMPS受理Bonvadis外用乳膏完全傷口適應症產品註冊申請","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-07-28 17:12，「公告本公司今日接獲註冊代理人通知，摩洛哥AMMPS受理Bonvadis外用乳膏完全傷口適應症產品註冊申請」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2025-07-28-1705-1tkkj4d","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2025-07-28","time":"17:05:34","subject":"公告本公司114年第二季財務報告董事會召開日期","clause":"第31款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2025-07-28 17:05，「公告本公司114年第二季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2025-07-28-1704-7xackn","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2025-07-28","time":"17:04:18","subject":"公告本公司董事長決議114年配息基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2025-07-28 17:04，「公告本公司董事長決議114年配息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-07-28-1702-1ieu8en","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-07-28","time":"17:02:12","subject":"本公司新藥CBL-514注射劑用於減少腹部皮下脂肪之多國多中心樞紐三期CBL-0301(SUPREME-01)臨床試驗申請，美國FDA已核准執行。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-07-28 17:02，「本公司新藥CBL-514注射劑用於減少腹部皮下脂肪之多國多中心樞紐三期CBL-0301(SUPREME-01)臨床試驗申」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4183-2025-07-28-1653-1t3n6rv","company_id":"4183","company":"福永生技","market":"上櫃","industry":"生技醫療","date":"2025-07-28","time":"16:53:27","subject":"公告114年第二季財務報告董事會召開日期","clause":"第31款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：福永生技（4183），2025-07-28 16:53，「公告114年第二季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4160-2025-07-28-1649-1yf90ck","company_id":"4160","company":"訊聯基因","market":"上櫃","industry":"生技醫療","date":"2025-07-28","time":"16:49:02","subject":"公告本公司114年第二季合併財務報告預計提報董事會","clause":"第31款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：訊聯基因（4160），2025-07-28 16:49，「公告本公司114年第二季合併財務報告預計提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2025-07-28-1632-1v89vf8","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2025-07-28","time":"16:32:42","subject":"公告本公司買回庫藏股期間屆滿執行情形","clause":"第35款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2025-07-28 16:32，「公告本公司買回庫藏股期間屆滿執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-07-28-1619-1rxywbt","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-07-28","time":"16:19:11","subject":"公告本公司新任永續長","clause":"第8款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-07-28 16:19，「公告本公司新任永續長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-07-28-1547-1hkj5dk","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-07-28","time":"15:47:34","subject":"係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-07-28 15:47，「係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-07-28-1531-yrpxkw","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-07-28","time":"15:31:08","subject":"代重要子公司永信藥品工業股份有限公司公告董事(含獨立董事)任期屆滿重新指派","clause":"第6款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-07-28 15:31，「代重要子公司永信藥品工業股份有限公司公告董事(含獨立董事)任期屆滿重新指派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-07-28-1530-o0aovs","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-07-28","time":"15:30:50","subject":"公告本公司背書保證達「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第四款之公告標準","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-07-28 15:30，「公告本公司背書保證達「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第四款之公告標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-07-28-1530-12c1r2l","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-07-28","time":"15:30:45","subject":"代重要子公司永信藥品工業股份有限公司公告第四屆審計委員會名單","clause":"第6款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-07-28 15:30，「代重要子公司永信藥品工業股份有限公司公告第四屆審計委員會名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4111-2025-07-28-1529-1jdpvd0","company_id":"4111","company":"濟生","market":"上櫃","industry":"生技醫療","date":"2025-07-28","time":"15:29:06","subject":"公告114年第二季財務報告董事會預計召開日期為114年8月6日","clause":"第31款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：濟生（4111），2025-07-28 15:29，「公告114年第二季財務報告董事會預計召開日期為114年8月6日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2025-07-28-1513-1c2e1g4","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2025-07-28","time":"15:13:28","subject":"公告本公司於董事會通過民國一一四年度第二季合併財務報告","clause":"第31款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2025-07-28 15:13，「公告本公司於董事會通過民國一一四年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2025-07-28-1512-1pzjlpi","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2025-07-28","time":"15:12:08","subject":"公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"第44款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2025-07-28 15:12，「公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-07-28-1510-egh2bq","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-07-28","time":"15:10:45","subject":"公告本公司公司治理主管暨代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-07-28 15:10，「公告本公司公司治理主管暨代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2025-07-28-1505-17fdons","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2025-07-28","time":"15:05:28","subject":"公告114年第2季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：立康（6242），2025-07-28 15:05，「公告114年第2季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2025-07-28-1502-1vkj4lt","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2025-07-28","time":"15:02:09","subject":"公告本公司民國114年第二季財務報告董事會預計召開日期為114年08月05日","clause":"第31款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：生達（1720），2025-07-28 15:02，「公告本公司民國114年第二季財務報告董事會預計召開日期為114年08月05日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4183-2025-07-28-1501-137nv24","company_id":"4183","company":"福永生技","market":"上櫃","industry":"生技醫療","date":"2025-07-28","time":"15:01:46","subject":"公告本公司審計委員會委員逝世","clause":"第6款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：福永生技（4183），2025-07-28 15:01，「公告本公司審計委員會委員逝世」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4183-2025-07-28-1500-t6mz3p","company_id":"4183","company":"福永生技","market":"上櫃","industry":"生技醫療","date":"2025-07-28","time":"15:00:25","subject":"公告本公司獨立董事逝世","clause":"第6款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：福永生技（4183），2025-07-28 15:00，「公告本公司獨立董事逝世」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2025-07-28-1439-tmd99p","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2025-07-28","time":"14:39:50","subject":"公告114年本公司第二季財務報告董事會召開日期為114年08月05日","clause":"第31款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2025-07-28 14:39，「公告114年本公司第二季財務報告董事會召開日期為114年08月05日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8409-2025-07-28-1351-6iiexc","company_id":"8409","company":"商之器","market":"上櫃","industry":"生技醫療","date":"2025-07-28","time":"13:51:45","subject":"公告本公司114年第二季財務報告提董事會決議日期","clause":"第31款","fact_date":"2025-07-28","cite_as":"公開資訊觀測站重大訊息：商之器（8409），2025-07-28 13:51，「公告本公司114年第二季財務報告提董事會決議日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}